Use of VEGF in the treatment of retarded fetal growth in pregnancy

An agonist of the VEGF receptor is useful in the treatment of a disease associated with retarded fetal growth, such as intra-uterine growth retardation. The VEGF agonist may be a VEGF peptide or a gene construct encoding or expressing such a peptide.

Saved in:
Bibliographic Details
Main Authors Martin, John Francis, Rodeck, Charles Henry
Format Patent
LanguageEnglish
Published 18.12.2012
Online AccessGet full text

Cover

More Information
Summary:An agonist of the VEGF receptor is useful in the treatment of a disease associated with retarded fetal growth, such as intra-uterine growth retardation. The VEGF agonist may be a VEGF peptide or a gene construct encoding or expressing such a peptide.